Q: What is Latisse?
A: Latisse is a bimatoprost ophthalmic solution 0.03%, originally 
developed and used as a glaucoma medication. In using the medication, many patients noticed that their eyelashes grew. Some even had to trim their lashes due to excessive length. Allergan, who owned the medication, began to market it as Latisse, for topical use in patients with “inadequate eyelashes.”
Q: How long has Latisse been on the market?
A: Although Latisse has been available for just over 6 months, its related safety record as an eye drop solution, spans over 10 years. Any medication that is used in the eye must be very safe.
Q: Why do I need a prescription for Latisse?
A: Latisse is not an over-the-counter medication. The FDA approved Latisse as a prescription medication to treat hypotrichosis, i.e. reduced amount of eyelash growth. Using Latisse can result in eyelash improvement of 105% in thickness and over 25% in length.
Q: How does Latisse work?
A: Latisse is thought to affect the growth stage of eyelashes by increasing the duration of the growth phase while increasing the number of hairs in the growth phase.
Sometimes new drugs make their way to the market inadvertently and become popular for uses that were never originally intended; such is the case with Allergan’s new eyelash enhancer, Latisse. 
